OncoCyte Corp (OCX) — Long-term Investment Intensity

Latest as of December 2020: 24.2%

OncoCyte Corp (OCX) has a Long-term Investment Intensity of 24.2% as of December 2020. Long-term investments of $13.42 Million represent 24.2% of total assets of $55.42 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check OncoCyte Corp total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

24.2%
LT Investments / Total Assets

Long-term Investments

$13.42 Million
USD

Total Assets

$55.42 Million
USD

Country

USA
NASDAQ

OncoCyte Corp Long-term Investment Intensity (2019–2020)

This chart shows how OncoCyte Corp's Long-term Investment Intensity has evolved across 2 annual periods from 2019 to 2020. As of December 2020, the intensity stands at 24.2%, reflecting long-term investments of $13.42 Million against total assets of $55.42 Million USD. Explore OCX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for OncoCyte Corp (2019–2020)

The table below presents the year-by-year Long-term Investment Intensity for OncoCyte Corp from 2019 to 2020, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see OCX company net worth.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2020 24.2% $13.42 Million $55.42 Million ▼ -3.3 pp
2019 27.5% $10.96 Million $39.86 Million
pp = percentage points